ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway

  1. Elizabeth Kopp,
  2. Ruslan Medzhitov,
  3. James Carothers,
  4. Changchun Xiao,
  5. Iris Douglas,
  6. Charles A. Janeway, and
  7. Sankar Ghosh
  1. Section of Immunobiology and Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute (HHMI), Yale University School of Medicine, New Haven, Connecticut 06520 USA

Abstract

Activation of NF-κB as a consequence of signaling through the Toll and IL-1 receptors is a major element of innate immune responses. We report the identification and characterization of a novel intermediate in these signaling pathways that bridges TRAF6 to MEKK-1. This adapter protein, which we have named ECSIT (evolutionarilyconserved signaling intermediate inToll pathways), is specific for the Toll/IL-1 pathways and is a regulator of MEKK-1 processing. Expression of wild-type ECSIT accelerates processing of MEKK-1, whereas a dominant-negative fragment of ECSIT blocks MEKK-1 processing and activation of NF-κB. These results indicate an important role for ECSIT in signaling to NF-κB and suggest that processing of MEKK-1 is required for its function in the Toll/IL-1 pathway.

Keywords

Footnotes

  • Corresponding author.

  • E-MAIL sankar.ghosh{at}yale.edu; FAX (203) 727-1764.

    • Received May 25, 1999.
    • Accepted July 6, 1999.
| Table of Contents

Life Science Alliance